Mission in Boston: Hemerion prepares its development in the United States
Hemerion has set new milestones for its international development during a 5-day mission in Boston. Read more
Category: Timeline Stories
All timeline stories.
Hemerion raises €3.55 million to accelerate the implementation of international clinical trials for the treatment of glioblastoma
One year after the first round of funding, Hemerion’s new €3.55 million financing will accelerate the implementation of international clinical trials for the treatment of glioblastoma. Read more – Press release
Hemerion awarded the Galien MedStartup Prize
Hemerion and Mount Sinai Health System (NYC) are collaborating to launch an ambitious clinical trial in 2022. This project has won the “Best Collaboration in the MedTech and Digital Health” award of the Galien Medstartup Prize: an international recognition that perfectly kickstarts the Hemerion development in the USA. Read more – Press release
Phase II study granted authorization in Europe
Authorization granted for a phase 2 clinical trial that aims to evaluate the technology developed by Hemerion. This study sponsored by Lille University Hopital (France) is multicentric with additional investigative center in Brussels (Erasme Hospital – Belgium).
Hemerion gathers 1.5M€ in funding
For its preliminary funding round, Hemerion gathers 1.5M€ in dilutive and non-dilutive funding to further validate its therapeutic approach.
University of Lille Foundation awards Hemerion Therapeutics
The University of Lille’s Foundation awards the Hemerion Therapeutics founders for their scientific and entrepreuneurship involvement establishing a healthtech company.
Entrepreneurship program with Eurasanté
The Hemerion’s founders enter the Eurasanté entrepreneurship program, an incubator dedicated to health start-up companies
Hemerion joins Neighborhood
Hemerion joins the Voisin Consulting Neighborhood program, a life science innovation center that offers tailored mentoring, coaching and global access to health tech entrepreneurs.
I-Lab innovation competition
Hemerion is awarded during I-Lab innovation competition and granted to upgrade its lead product and better meet neurosurgeons needs.
Preliminary results published in Journal of Neuro-Oncology
Ground breaking preliminary results from the clinical study are published in the Journal of Neuro-Oncology. The Hemerion’s technology covered the 2018’s May issue. Read more